Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of UBT251 Injection in Patients With Type 2 Diabetes Mellitus
NCT07163624Phase 2Completed
- Start
- Mar 2025
- Primary completion
- Nov 2025
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of UBT251 in type 2 diabetes mellitus (T2DM). Started Mar 2025; status: completed.
02
Drugs
UBT251
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07163624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163624.